Although many infectious diseases lack vaccines, current vaccine research is limited, primarily due to an understandable but unfortunate lack of commercial interest
Although many infectious diseases lack vaccines, current vaccine research is limited, primarily due to an understandable but unfortunate lack of commercial interest. A new article identifies and discusses the gaps in human capital necessary for robust vaccine development.
The authors recommend the formation of an institute that will focus on the development of vaccines that are of obvious public health importance but not necessarily of commercial interest. An advisory committee of key stakeholders from, industry, government, academia, and private foundations should agree to the goals, structure, and governance for this institute; identify the ideal training program for future vaccine researchers; and agree on the degree of contributions available from each stakeholder.
“We look forward to advancing approaches to increase trained and experienced human capital that promote robust beginning-to-end vaccine development,” said Dr. William Gruber, senior author of the Annals of the New York Academy of Sciences article.
Additional Information
Link to study: http://doi.wiley.com/10.1111/nyas.13316
About Journal
Annals of the New York Academy of Sciences is one of the oldest published scientific journals published in the United States, and among the top five cited multidisciplinary scientific journals worldwide. Continuously published since 1823, Annals of the New York Academy of Sciences is the premier publication of the New York Academy of Sciences, offering commissioned review, perspective, and commentary articles in several topical areas, in addition to original research articles in select areas of biological sciences. Although primarily focused in biomedicine and biology, the scope of Annals extends into diverse fields such as psychology, anthropology, and philosophy. Edited in consultation with experts in their fields, Annals of the New York Academy of Sciences is rigorously peer reviewed and available worldwide.
Lauren Elkins
+44 (0) 1243 770694
sciencenewsroom@wiley.com